XECHEM INTERNATIONAL INC
NT 10-Q, 1996-08-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: BERRY PLASTICS CORP, 10-Q, 1996-08-13
Next: CKE RESTAURANTS INC, POS AM, 1996-08-13



                    U.S. SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                          NOTIFICATION OF LATE FILING

                                  FORM 12b-25

SEC File Number  0-23788                 Cusip Number  983895
               ----------------------                --------

                                  [Check One]
     [ ] Form 10[ ] Form 20-F[ ] Form 11-[ X ] Form 10-[ ] Form N-SAR

                  For the Period Ended:        June 30, 1996

                  [ ] Transition  Report on Form 10-K [ ]  Transition  Report on
                  Form 20-F [ ]  Transition  Report on Form 11-K [ ]  Transition
                  Report on Form 10-Q [ ]  Transition  Report on Form  N-SAR For
                  the Transition Period Ended


            Read Instructions [on back page] Before Preparing Form.
                             Please Print or Type
Nothing                  in this form  shall be  constructed  to imply  that the
                         Commission  has  verified  any  information   contained
                         herein
If                the  notification  relates to a portion of the filing  checked
                  above, identify the Item[s] to which the notification relates:


PART I - REGISTRANT  INFORMATION  Full Name of  Registrant:XECHEM  INTERNATIONAL
INC.
Former Name if Applicable:
Address of Principal Executive Office [Street and Number]:100 Jersey Ave - B310

City, State and Zip Code:  New Brunswick, NJ 08901

PART II - RULES 12b-25[b] and [c]
If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25[b], the following should
be completed.
                          [Check box if appropriate]

{ x}  [a] The reasons  described in  reasonable  detail in Part III of this form
          could not be eliminated without unreasonable effort or expenses;

      [b] The subject annual report,  semi-annual report, transition report
          on Form 10-K,  Form 2-F, Form 11-K,  Form N-SAR,  or portion thereof ,
          will be filed on or before the  fifteenth  calendar day  following the
          prescribed  due date;  or the subject  quarterly  report or transition
          report on Form 10-Q, or portion thereof will be filed on or before the
          fifth calendar day following the prescribed due date; and

      [c] The accountant's statement or other exhibit required by Rule 12b-25[c]
          has been attached if applicable.


PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, 
10-Q or N-SAR, or the transition report or portion thereof, could not be
 filed within the prescribed time period.  [Attach Extra Sheet if Needed]

PART IV - OTHER INFORMATION
    [1]  Name and telephone number of person to contact in regard to this
 notification

                   Leonard A. Mudry                 908              247-3300
                   [Name]                      [Area Code]      [Telephone No.]

    [2] Have all other  periodic  reports  required under Section 13 or 15[d] of
        the  Securities and Exchange Act of 1934 or Section 30 of the Investment
        Company Act of 1940 during the  preceding 12 months [or for such shorter
        period  that the  registrant  was  required to file such  reports]  been
        filed? If answer is no, identify report[s]. [ ] Yes [ X ] No



    [3] Is it anticipated that any significant change in results of operations
        from the corresponding period for the last fiscal year will be
        reflected by the earnings statements to be included in the
        subject report or portion thereof?      [   ] Yes     [ x ] No

        If so, attach an explanation of the anticipated change, both narratively
        and  quantitatively,  and,  if  appropriate,  state  the  reasons  why a
        reasonable estimate of the results cannot be made.



                                                Xechem International, Inc.
                  [Name of Registrant as Specified in Charter]

has caused this notification to be signed on its behalf by the undersigned 
thereunto duly authorized.

Date        August 14, 1996                        By    Leonard A. Mudry
    -----------------------------------------        --------------------

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
[other than an executive officer], evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION
           Intentional misstatements or omissions of fact constitute
                Federal Criminal Violation  [See 18 U.S.C. 1001]

                              GENERAL INSTRUCTIONS

1.  This form is  required  by Rule  12b-25 [17 CFR  240.12b-25]  of the General
    Rules and Regulations under the Securities Exchange Act of 1934.

2.  One signed  original and four  conformed  copies of this form and amendments
    thereto  must be  completed  and  filed  with the  Securities  and  Exchange
    Commission,  Washington,  D.C.  20549,  in  accordance  with Rule 0-3 of the
    General Rules and Regulations under the Act. The information contained in or
    filed  with  the form  will be made a matter  of the  public  record  in the
    Commission files.

3.  A manually  signed copy of the form and  amendments  thereto  shall be filed
    with each national  securities  exchange on which any class of securities of
    the registrant is registered.

4   Amendments to the notifications  must also be filed on form 12b-25, but need
    not restate information that has been correctly furnished. The form shall be
    clearly identified as an amendment notification.



<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission